Jun. 17 – Israeli radiotherapy positioning start up, Navotek Medical, has raised some $10 million in a financing round led by Giza Venture Capital. Existing investors Agate Medical Investments, Wanaka Capital, Bridge Investments Fund, and chairman and co-founder Dr. Shimon Eckhouse, also took part in the round. Navotek was founded four years ago and develops products to precisely locate and track tumors. This leads to greater efficiency in radiotherapy and chemotherapy, and a reduction in damage to healthy tissue. The technology is based on a tracer implanted in the growth, which can be tracked during treatment, even if the growth moves. It is used in prostate surgery and other soft tissue treatment. This is the third year in a row that the company has raised financing. All together it has raised a sum of about $25 million. Navotek hopes to receive US Food and Drug Administration (FDA) approval in the second half of this year.
the Israel we love
For over 16 years, ISRAEL21c has brought you the faces and places of Israel every day, spreading the word about Israel to millions of people in virtually every country around the globe. First of its kind, our content is originally researched, written and produced by seasoned experts directly from Israel.
We cannot do this without financial support from people like you. Become a GEM member and enjoy exclusive briefings from our staff and more - for $18 a month.
Free by Email